Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Consumer Cyclical Healthcare Advertising Agencies Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Algernon added to World's First Psychedelics ETF fund
View:
Post by talisman47 on Mar 26, 2021 9:46pm

Algernon added to World's First Psychedelics ETF fund

https://www.stockwatch.com/News/Item/Z-C!AGN-3054352/C/AGN
Comment by BitHorse on Mar 26, 2021 11:21pm
This post has been removed in accordance with Community Policy
Comment by talisman47 on Mar 27, 2021 4:22pm
As of December, 2020 they have Public equity investments in  Algernon Pharmaceuticals Inc. - 6,958,800  shares - 2,000,000  warrants Stockwatch indicates as of Friday the stock was still halted ( maybe that changes early this week ? )
Comment by talisman47 on Mar 27, 2021 4:24pm
To clarify I meant to mention I was refering to Growmax Capital As of December, 2020 they have Public equity investments in  Algernon Pharmaceuticals Inc. - 6,958,800  shares - 2,000,000  warrants Stockwatch indicates as of Friday the stock was still halted ( maybe that changes early this week ? )
Algernon Pharmaceuticals Inc.